Patients in a hospital's emergency department are to be tested for blood-borne viruses like HIV. The pilot project at ...

Through the use of phylogenetics, we now know that HIV-1 and -2 originated in central and west Africa, respectively. HIV-1, sub-classified in groups and subtypes, is present worldwide and exhibits ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.

Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

Despite high rates of untreated osteoporosis and previous fractures among menopausal women in Zimbabwe -- especially among those living with human immunodeficiency virus (HIV) -- the FRAX® tool ...

Gilead and Merck & Co. have guided their once-weekly HIV combination therapy past another milestone, linking the cocktail to ...

The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Gilead Sciences Inc. (GILD) and Merck & Co Inc.(MRK) announced new results from a Phase 2 clinical study evaluating the ...

Two posters compared health care resource utilization (HCRU) and financial burdens of people living with HIV with a non-HIV ...